• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载药量高且能持续释放 siRNA 的 PLGA 纳米粒:基于质量源于设计的优化和表征。

High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.

机构信息

Department of Pharmaceutics and Analytical Chemistry, University of Copenhagen, Copenhagen Ø, Denmark.

出版信息

Eur J Pharm Biopharm. 2011 Jan;77(1):26-35. doi: 10.1016/j.ejpb.2010.11.008. Epub 2010 Nov 18.

DOI:10.1016/j.ejpb.2010.11.008
PMID:21093589
Abstract

Poly(DL-lactide-co-glycolide acid) (PLGA) is an attractive polymer for delivery of biopharmaceuticals owing to its biocompatibility, biodegradability and outstanding controlled release characteristics. The purpose of this study was to understand and define optimal parameters for preparation of small interfering RNA (siRNA)-loaded PLGA nanoparticles by the double emulsion solvent evaporation method and characterize their properties. The experiments were performed according to a 2(5-1) fractional factorial design based on five independent variables: The volume ratio between the inner water phase and the oil phase, the PLGA concentration, the sonication time, the siRNA load and the amount of acetylated bovine serum albumin (Ac-BSA) in the inner water phase added to stabilize the primary emulsion. The effects on the siRNA encapsulation efficiency and the particle size were investigated. The most important factors for obtaining an encapsulation efficiency as high as 70% were the PLGA concentration and the volume ratio whereas the size was mainly affected by the PLGA concentration. The viscosity of the oil phase was increased at high PLGA concentration, which explains the improved encapsulation by stabilization of the primary emulsion and reduction of siRNA leakage to the outer water phase. Addition of Ac-BSA increased the encapsulation efficiency at low PLGA concentrations. The PLGA matrix protected siRNA against nuclease degradation, provided a burst release of surface-localized siRNA followed by a triphasic sustained release for two months. These results enable careful understanding and definition of optimal process parameters for preparation of PLGA nanoparticles encapsulating high amounts of siRNA with immediate and long-term sustained release properties.

摘要

聚(DL-丙交酯-co-乙交酯酸)(PLGA)因其生物相容性、可生物降解性和出色的控制释放特性,是一种用于生物制药递送的有吸引力的聚合物。本研究的目的是了解和定义通过双乳液溶剂蒸发法制备载有小干扰 RNA(siRNA)的 PLGA 纳米粒的最佳参数,并对其性质进行表征。实验根据基于五个独立变量的 2(5-1)分数部分设计进行:内水相与油相的体积比、PLGA 浓度、超声时间、siRNA 负载和添加到内水相中稳定初级乳液的乙酰化牛血清白蛋白(Ac-BSA)的量。考察了这些变量对 siRNA 包封效率和粒径的影响。获得高达 70%的包封效率的最重要因素是 PLGA 浓度和体积比,而粒径主要受 PLGA 浓度的影响。高 PLGA 浓度会增加油相的粘度,这解释了通过稳定初级乳液和减少 siRNA 向外部水相泄漏来提高包封效率的原因。添加 Ac-BSA 可提高低 PLGA 浓度下的包封效率。PLGA 基质可保护 siRNA 免受核酸酶降解,并提供表面定位 siRNA 的快速释放,随后持续两个月的三相缓释。这些结果使我们能够仔细了解和定义制备包封大量 siRNA 的 PLGA 纳米粒的最佳工艺参数,这些纳米粒具有即刻和长期持续释放的特性。

相似文献

1
High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.载药量高且能持续释放 siRNA 的 PLGA 纳米粒:基于质量源于设计的优化和表征。
Eur J Pharm Biopharm. 2011 Jan;77(1):26-35. doi: 10.1016/j.ejpb.2010.11.008. Epub 2010 Nov 18.
2
Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.聚(DL-丙交酯-共-乙交酯)纳米粒的制备及特性研究及其在 siRNA 递送中的应用。
Int J Pharm. 2010 May 5;390(1):70-5. doi: 10.1016/j.ijpharm.2009.10.023. Epub 2009 Oct 15.
3
Polymeric nanoparticles for siRNA delivery and gene silencing.用于siRNA递送和基因沉默的聚合物纳米颗粒。
Int J Pharm. 2009 Feb 9;367(1-2):195-203. doi: 10.1016/j.ijpharm.2008.09.039. Epub 2008 Oct 1.
4
Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency.用于小干扰RNA(siRNA)持续释放的包裹siRNA的聚乳酸-羟基乙酸共聚物(PLGA)纳米颗粒的制备及包封率评估。
Methods Mol Biol. 2012;906:311-9. doi: 10.1007/978-1-61779-953-2_25.
5
Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.改良的纳米沉淀法制备载 DNA 的 PLGA 纳米粒。
Drug Dev Ind Pharm. 2009 Nov;35(11):1375-83. doi: 10.3109/03639040902939221.
6
Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.载氟哌啶醇的聚乳酸-羟基乙酸共聚物纳米粒:粒径与药物含量的系统研究
Int J Pharm. 2007 May 24;336(2):367-75. doi: 10.1016/j.ijpharm.2006.11.061. Epub 2006 Dec 5.
7
Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.通过纳米晶体和水溶性聚合物模板技术提高灯盏花素在聚乳酸-羟基乙酸共聚物微粒中的包封率和生物利用度。
Eur J Pharm Biopharm. 2017 Jun;115:177-185. doi: 10.1016/j.ejpb.2017.02.021. Epub 2017 Mar 2.
8
[Effect of NaCl in outer water phase on the characteristics of BSA-loaded PLGA sustained-release microspheres fabricated by a solid-in-oil-in-water emulsion technique].[外水相中NaCl对水包油包固乳液技术制备的载牛血清白蛋白聚乳酸-羟基乙酸共聚物缓释微球特性的影响]
Yao Xue Xue Bao. 2010 Aug;45(8):1057-63.
9
Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.载比卡鲁胺聚乳酸-羟基乙酸共聚物纳米粒的研制:制备、表征及前列腺癌治疗的体外评价
Artif Cells Nanomed Biotechnol. 2017 Aug;45(5):944-954. doi: 10.1080/21691401.2016.1196457. Epub 2016 Jun 21.
10
Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.通过自发乳液扩散法制备用于小干扰RNA递送的聚乙二胺掺入的聚(D,L-丙交酯-共-乙交酯)纳米颗粒。
Int J Pharm. 2009 Mar 18;369(1-2):144-54. doi: 10.1016/j.ijpharm.2008.10.012. Epub 2008 Nov 1.

引用本文的文献

1
Immune Modulation with Oral DNA/RNA Nanoparticles.口服DNA/RNA纳米颗粒的免疫调节
Pharmaceutics. 2025 May 4;17(5):609. doi: 10.3390/pharmaceutics17050609.
2
Arginase 1 drives mitochondrial cristae remodeling and PANoptosis in ischemia/hypoxia-induced vascular dysfunction.精氨酸酶1在缺血/缺氧诱导的血管功能障碍中驱动线粒体嵴重塑和PAN凋亡。
Signal Transduct Target Ther. 2025 May 28;10(1):167. doi: 10.1038/s41392-025-02255-2.
3
Topical miRNA Delivery via Elastic Liposomal Formulation: A Promising Genetic Therapy for Cutaneous Lupus Erythematosus (CLE).
通过弹性脂质体制剂进行局部miRNA递送:一种有前景的皮肤红斑狼疮(CLE)基因治疗方法。
Int J Mol Sci. 2025 Mar 14;26(6):2641. doi: 10.3390/ijms26062641.
4
Prilling as an Effective Tool for Manufacturing Submicrometric and Nanometric PLGA Particles for Controlled Drug Delivery to Wounds: Stability and Curcumin Release.喷雾干燥作为制备用于伤口药物控释的亚微米级和纳米级聚乳酸-羟基乙酸共聚物(PLGA)颗粒的有效工具:稳定性和姜黄素释放
Pharmaceutics. 2025 Jan 17;17(1):129. doi: 10.3390/pharmaceutics17010129.
5
Progress in Nanotechnology for Treating Ocular Surface Chemical Injuries: Reflecting on Advances in Ophthalmology.用于治疗眼表化学伤的纳米技术进展:眼科进展反思
Adv Sci (Weinh). 2025 Feb;12(6):e2407340. doi: 10.1002/advs.202407340. Epub 2025 Jan 4.
6
Nanomaterial-enabled drug transport systems: a comprehensive exploration of current developments and future avenues in therapeutic delivery.纳米材料驱动的药物输送系统:治疗性给药当前进展与未来方向的全面探索
3 Biotech. 2024 Dec;14(12):289. doi: 10.1007/s13205-024-04135-y. Epub 2024 Nov 4.
7
Investigating the Immunomodulatory Effects of Antigenic PLGA Nanoparticles and Nutritional Synergy in .研究抗原性聚乳酸-羟基乙酸共聚物纳米颗粒的免疫调节作用及营养协同作用于…… (原文结尾不完整)
Bionanoscience. 2024 Nov;14(4):4493-4505. doi: 10.1007/s12668-024-01330-2. Epub 2024 Feb 14.
8
Exosomal fragment enclosed polyamine-salt nano-complex for co-delivery of docetaxel and mir-34a exhibits higher cytotoxicity and apoptosis in breast cancer cells.外泌体包裹多胺盐纳米复合物共递送多西他赛和 mir-34a 可提高乳腺癌细胞的细胞毒性和促凋亡作用。
Sci Rep. 2024 Sep 17;14(1):21669. doi: 10.1038/s41598-024-72226-0.
9
Functional Nanomaterials for the Treatment of Osteoarthritis.用于治疗骨关节炎的功能纳米材料
Int J Nanomedicine. 2024 Jul 4;19:6731-6756. doi: 10.2147/IJN.S465243. eCollection 2024.
10
Multifunctional elastin-like polypeptide nanocarriers for efficient miRNA delivery in cancer therapy.多功能弹性蛋白样多肽纳米载体用于癌症治疗中的高效 miRNA 递送。
J Nanobiotechnology. 2024 May 27;22(1):293. doi: 10.1186/s12951-024-02559-5.